Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -49.35 | 10.63 |
PEG Ratio (TTM) | 2.22 | 10.15 |
P/S Ratio (TTM) | 2.11 | 2.54 |
P/B Ratio (TTM) | 10.75 | 5.75 |
P/FCF Ratio (TTM) | 27.18 | 18.42 |
Price to 5YR AVG Earnings Ratio | -13.60 | 25.30 |
Price to 5YR AVG FCF Ratio | -63.47 | 20.17 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.31% | 7.47% |
ROE (TTM) | -22.04% | 25.08% |
Net Profit Margin (TTM) | -4.19% | 11.14% |
ROIC 5YR AVG | -1,700.47% | -25.37% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -310.86% | 7.30% | 17.88% |
Revenue | 2.86% | -1.08% | 1.92% |
Net Income | -316.73% | 0.39% | 12.24% |
Cash Flow | 11.98% | -135.12% | -64.03% |
Health (42%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.48 | 1.95 |
Quick Ratio (TTM) | 1.23 | 1.47 |
D/E Ratio (TTM) | 0.19 | 2.02 |
Interest Coverage (TTM) | 33.13 | 13.52 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 3.34 | 4.47 |
LTL to 5YR AVG FCF | -0.99 | 1.08 |
Shares Outstanding Growth 5YR AVG | 6.68% | 3.99% |